Newsletter - Banner
Research team from the Lady Davis Institute, RI-MUHC and SickKids uses new technologies to “interrogate” tumour cells
November 25, 2019
Montreal – A research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado, of the Research Institute of the McGill University Health Centre (RI-MUHC), and Dr. Michael Taylor, of The Hospital for Sick Children (SickKids), discovered that several types of highly aggressive and, ultimately, fatal pediatric brain tumours originate during brain development. The genetic event that triggers the disease happens in the very earliest phases of cellular development, most likely prenatal. The findings represent a significant advance in understanding these diseases, and are published in Nature Genetics.
“We have determined that stalled development of progenitor cells in the pons and forebrain, where a large proportion of high-grade embryonal and pediatric tumours emerge, is responsible for several childhood brain cancers,” said Dr. Kleinman, an Assistant Professor of Human Genetics at McGill University. “Rather than developing normally, the cells’ progress is arrested and they transform into malignancies. But they retain many features of the original cells, and we could pinpoint the tumour origins among the hundreds of different cell types present in the brain.”
“New technologies allowing us to interrogate tumour cells each one at a time points to stalled development at the root of several high grade brain tumours in children,” added Dr. Jabado, who is also a hemato-oncologist at the Montreal Children’s Hospital of the MUHC and a professor of Pediatrics and Human Genetics at McGill University. “We name this the Peter Pan Syndrome as these cells are stuck in time unable to age and this is what causes these tumours. The challenge is now to identify how best to unlock these cells promoting their differentiation, and allowing for normal processes to take over.”
Brain tumours are the leading cause of cancer-related deaths in children. For several of these tumours, there are no effective therapies and survival is often less than two years. Indeed, Dr. Kleinman points out, very limited progress has been made in treating afflicted children.
“The cornerstone to fighting these conditions is to identify the biological process at work, which is what our research has achieved,” she said. “Once we understand the underlying mechanisms, the search can begin for the means to unblock the arrested development of the cells. The complexity of the brain is astounding, and we now have narrowed down where to search.”
Applying sophisticated single cell sequencing techniques and large-scale data analysis, researchers compiled the first comprehensive profile of the normal prenatal pons, a major structure on the upper part of the brainstem that controls breathing, as well as sensations including hearing, taste, and balance.
While Dr. Jabado, and her team in the Child Health and Human Development Program at the RI-MUHC, and Dr. Taylor, Paediatric Neurosurgeon and Senior Scientist in Developmental and Stem Cell Biology at SickKids, undertook much of the clinical research, Dr. Kleinman’s team performed the bio-informatics and establishing the molecular identity for cell types in this and other brain regions, as well as the dynamics underlying their differentiation. They created an atlas of more than 65,000 individual cells and defined the developmental dynamics for 191 distinct cell populations. They then mapped patient samples to this atlas, and identified the origins of WNT medulloblastomas, embryonal tumours with multilayered rosettes (ETMRs), and high grade gliomas (HGGs).
This work is the result of extensive international collaborations that include researchers from across Quebec, Canada, the United States, and France. Summarizing their achievement, the authors of the paper, “Stalled developmental programs at the root of pediatric brain tumours,” wrote, “Current evidence thus supports a common etiological model for these tumours, where genetic alterations in vulnerable cell types disrupt developmental gene expression programs, ultimately leading to oncogenesis.”
The genesis of the tumours is very early in brain development, which means that there are really no environmental instigators or preventive measures that parents can take,” Dr. Kleinman said. “Advancing our understanding of these tumours is important because the effects are so devastating, we want to bring hope to the patients.”
This work was supported by funding from Genome Quebec, Genome Canada, the Government of Canada and the Ministère de l'Économie, de la Science et de l’Innovation du Québec, with the support of the Ontario Research Fund; the Canadian Institutes for Health Research; the US National Institutes of Health; the Canadian Cancer Society, National Sciences and Engineering Research Council, the Fonds de recherche du Québec – Santé , and the Fondation Charles-Bruneau, among others. Data analyses were enabled by computer and storage resources provided by Compute Canada and Calcul Québec.
“Stalled developmental programs at the root of pediatric brain tumours,” Selin Jessa et al, Nature Genetics, https://www.nature.com/articles/s41588-019-0531-7
For media inquiries and to arrange interviews with Dr. Kleinman, contact:
Tod Hoffman Research
Lady Davis Institute
Tel.: 514-340-8222 x 28661
For media inquiries and to arrange interviews with Dr. Jabado, contact:
Media Relations Officer, Research McGill University Health Centre
Cell 514 812-7722
For more about the Lady Davis Institute: www.ladydavis.ca
For more about the Jewish General Hospital: www.jgh.ca
For more information about the Research Institute of the McGill University Health Centre: rimuhc.ca
For more information about the McGill University Health Centre: muhc.ca